However, a recent preprint article reports that liver from NASH-prone patients exhibit an enrichment of several transcription factor motifs located at enhancers that are shared with our data, including MAFK, TCF3 (with similar motif to TCF4), JUND, ATF3 and BACH2 among others20. Here, MAFK is linked to metabolic dysfunction-associated steatohepatitis.